Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-02-14

Clinical Trial Update: Nicotine Virtual Reality Conditioned Place Preference [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial studying nicotine virtual reality conditioned place preference was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Chicago | Conditions: Nicotine Addiction, Nicotine Use Disorder | Phase 4 | Status: WITHDRAWN